New research points to progress on the HOA front


Examining why wavefront guided ablation provides the best optical results in the majority of patients.

Key Points

Over the last several years, the research community has made a concerted effort to better understand this relationship between HOAs and visual acuity, with compelling results. A number of studies now indicate that in order to achieve optimal outcomes with refractive surgery, ophthalmologists need to target for zero ocular aberrations.2 One study in particular was able to show causation between greater HOAs and poorer postoperative best corrected visual acuity (BCVA) (Figure 1).3

In theory, these findings would suggest that one of today's available LASIK strategies would be more successful than the others. Current options include:

ii) wavefront 'optimized' LASIK, which attempts to maintain preoperative HOAs

iii) wavefront 'guided' LASIK, which strives to reduce or possibly even eliminate all HOAs.

I recently conducted a study to test this theory, and took a retrospective look at the relationship between HOAs and visual outcomes in patients who had received 'wavefront optimized' and 'wavefront guided 'ablations.4 We were able to conclude, as outlined below, that for the majority of patients, nearly 90% in our study, wavefront guided LASIK provided better optical results than wavefront optimized LASIK.

Optimized vs. guided

During the last quarter of 2005 and 2006, I performed both wavefront optimized and wavefront guided laser procedures. Wavefront optimized ablations were performed with the Wavelight Allegretto Wave (Sterling) laser whose treatment is based on sphere and cylinder, while wavefront guided ablations were carried out by the Advanced Medical Optics (AMO) combined Wavescan and Visx Star4 excimer laser, CustomVue, whose treatment is based on wavefront. All flaps were created with the IntraLase femtosecond laser (AMO), as it has become my standard of care.

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Thomas Bosshard stands at the Oertli Instruments booth at the ESCRS meeting
Eva Kim, MD, speaks about her presentation on ICL versus CLE at the Women in Ophthalmology Summer Symposium 2023 in Marco Island, Florida.
Trukera Medical rebranding ushers in new era of expansion into cornea market
© 2023 MJH Life Sciences

All rights reserved.